Search | Page 2 | Aplastic Anemia and MDS International Foundation


Search results

  1. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... complete remission (CR) High-risk MDS status-post cytotoxic chemotherapy Burkitt's lymphoma: second or subsequent CR ... lymphomas that have failed at least 1 prior regimen of multi-agent chemotherapy and are ineligible for an autologous transplant Marginal ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.